2018 Ebola virus epidemic in Équateur province

2018 Ebola virus epidemic in Équateur province
Name	2018 Ebola virus epidemic in Équateur province
Disease	Ebola virus disease
Virus strain	Zaire ebolavirus
Location	Équateur province, Democratic Republic of the Congo
Dates	May–July 2018
Confirmed cases	54
Suspected cases	43
Deaths	33
Origin	Bikoro health zone
Reported by	World Health Organization

2018 Ebola virus epidemic in Équateur province The 2018 Ebola virus epidemic in Équateur province was a localized outbreak of Ebola virus disease caused by Zaire ebolavirus that occurred in Équateur province in the Democratic Republic of the Congo from May to July 2018. The event drew rapid attention from the World Health Organization, Ministry of Public Health (Democratic Republic of the Congo), and international partners including Médecins Sans Frontières, Centers for Disease Control and Prevention, and World Bank. Containment efforts employed rVSV-ZEBOV vaccine, surveillance, and community engagement, limiting spread beyond the affected zones of Bikoro, Iboko, and Mbandaka.

Background

The outbreak emerged within a context shaped by prior Ebola virus disease events such as the 2014–2016 West African Ebola epidemic and earlier Central African outbreaks in Gabon and Republic of the Congo. Équateur province had health infrastructure constraints influenced by historical administration under the Belgian Congo period and postcolonial governance in the Democratic Republic of the Congo. Regional transport links along the Congo River connected remote health zones including Bikoro, Mbandaka, and Iboko to national nodes like Kinshasa and international hubs such as Brazzaville. Surveillance capacity involved institutions like the Institut National de Recherche Biomédicale and laboratories coordinated with the Pasteur Institute network and the World Health Organization Regional Office for Africa.

Outbreak chronology

Initial suspicious deaths were reported in late April and May 2018 from Bikoro health zone. Laboratory confirmation of Zaire ebolavirus occurred in May at the Institut National de Recherche Biomédicale laboratory in Kinshasa and international reference laboratories such as those linked to the Centers for Disease Control and Prevention and Institut Pasteur. Public alerts triggered activation of Emergency Operations Center (DRC) mechanisms and deployment of rapid response teams from Ministry of Public Health (Democratic Republic of the Congo), Médecins Sans Frontières, International Federation of Red Cross and Red Crescent Societies, and UNICEF. Case investigations traced transmission chains to health facilities and funerary practices in Bikoro and patient movements to Mbandaka, a major port on the Congo River, raising concerns about riverine and urban transmission. By June, the World Health Organization declared a public health event of international concern for monitoring while emphasizing localized response. Surveillance, contact listing, and ring vaccination operations were implemented in affected health zones and in at-risk areas linked by transport routes to Kinshasa.

Public health response

Response coordination included the Ministry of Public Health (Democratic Republic of the Congo), World Health Organization, Médecins Sans Frontières, Centers for Disease Control and Prevention, International Federation of Red Cross and Red Crescent Societies, UNICEF, Gavi, the Vaccine Alliance, and the World Bank. Measures comprised case isolation in ETCs operated by Médecins Sans Frontières and national teams, contact tracing by public health rapid response teams, safe and dignified burials by International Federation of Red Cross and Red Crescent Societies volunteers, infection prevention and control in health facilities, and community engagement led by local health committees and faith leaders in Bikoro and Mbandaka. The experimental rVSV-ZEBOV vaccine was deployed under a ring vaccination strategy coordinated with Gavi, the Vaccine Alliance and regulatory oversight from the World Health Organization Strategic Advisory Group of Experts on Immunization. Laboratory confirmation relied on PCR at the Institut National de Recherche Biomédicale and partner laboratories including the Centers for Disease Control and Prevention and Institut Pasteur.

Impact and casualties

The outbreak resulted in dozens of cases and multiple deaths centered in Bikoro, Iboko, and Mbandaka. Health workers from institutions such as local clinics and teams dispatched by Médecins Sans Frontières were affected, prompting intensified protection measures and provision of personal protective equipment from partners including the World Health Organization and UNICEF. The event strained referral pathways to hospitals in Mbandaka and prompted transport arrangements involving river vessels and coordination with Monusco for logistical support. Economic and social effects were concentrated in affected health zones, with disruptions to markets in Bikoro and port activities along the Congo River near Mbandaka.

International involvement

International responders included World Health Organization, Centers for Disease Control and Prevention, Médecins Sans Frontières, International Federation of Red Cross and Red Crescent Societies, UNICEF, Gavi, the Vaccine Alliance, World Bank, and bilateral agencies from countries such as Belgium, United States, and United Kingdom. Technical support arrived from reference laboratories including the Institut Pasteur and regional networks coordinated by the World Health Organization Regional Office for Africa. Logistics and security assistance involved Monusco and national armed forces for safe access to remote health zones. Research partnerships engaged with academic centers and public health institutes such as Johns Hopkins University, London School of Hygiene & Tropical Medicine, and the University of Kinshasa to analyze transmission dynamics and evaluate vaccine deployment strategies.

Aftermath and preparedness improvements

Following containment, lessons fed into strengthened national and regional capacity building. The Ministry of Public Health (Democratic Republic of the Congo) revised rapid response protocols, increased laboratory network capacity at the Institut National de Recherche Biomédicale, and expanded training with partners like World Health Organization and Médecins Sans Frontières. Vaccination experiences with rVSV-ZEBOV vaccine informed subsequent deployments during later outbreaks in North Kivu and Ituri provinces and contributed to policy discussions at Gavi, the Vaccine Alliance and the World Health Organization Strategic Advisory Group of Experts on Immunization. Investments from World Bank and bilateral donors supported surveillance, emergency operations centers, and community engagement frameworks tied to health zones along the Congo River. The outbreak reinforced international collaboration mechanisms exemplified by joint operations involving UNICEF, International Federation of Red Cross and Red Crescent Societies, and Centers for Disease Control and Prevention to improve readiness for future Ebola virus disease threats.

Category:Ebola virus outbreaks Category:2018 in the Democratic Republic of the Congo